Lexacalcitol
| Title | Journal |
|---|---|
| Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action. | Laboratory investigation; a journal of technical methods and pathology 20110101 |
| Synergistic induction of gene expression during the differentiation into mature macrophage in human myeloblastic leukemia cells treated with TPA and KH1060. | Leukemia research 20090601 |
| Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. | Endocrinology 20080701 |
| Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. | International immunopharmacology 20060701 |
| Vitamin D receptor: ligand recognition and allosteric network. | Journal of medicinal chemistry 20060223 |
| Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050701 |
| Biochemical effects of KH 1060 and anti-TNF monoclonal antibody on human peripheral blood mononuclear cells. | International immunopharmacology 20050401 |
| Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. | Journal of medicinal chemistry 20041230 |
| 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells. | Journal of cellular biochemistry 20030815 |
| Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. | Biochemical pharmacology 20030801 |
| 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. | Experimental eye research 20030701 |
| Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1). | Cancer letters 20030210 |
| Involvement of diverse protein kinase C isoforms in the differentiation of ML-1 human myeloblastic leukemia cells induced by the vitamin D3 analogue KH1060 and the phorbol ester TPA. | Cancer letters 20021201 |
| Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. | The American journal of gastroenterology 20020301 |
| Synergistic effect of vitamin D derivatives and retinoids on C2C12 skeletal muscle cells. | IUBMB life 20020301 |
| A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice. | Transplantation proceedings 20010501 |
| Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. | Clinical immunology (Orlando, Fla.) 20010401 |
| Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis. | Biochemical pharmacology 20010201 |
| Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line. | Cancer letters 19960227 |
| Studies on two new vitamin D analogs, EB 1089 and KH 1060: effects on bone resorption and osteoclast recruitment in vitro. | Bone 19951001 |